Search

everythinglearnresearchcommunity

for

Search:↓

Non-coding RNAs help control hair growth cycles in cashmere goats, suggesting ways to improve cashmere production.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

DNAJB9 cfRNA could help diagnose and treat female hair loss.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

CTHRC1 helps sweat glands recover by rebuilding nearby blood vessels.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

NAC1 controls certain enzymes that reduce root hair growth in Arabidopsis.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

A specific RNA can help hair growth in baldness by boosting stem cell activity.

A new treatment using special nanovesicles with linoleic acid shows promise in improving hair growth and reducing irritation for hair loss.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

Using growth factors with microneedling is effective for treating hair loss.

Neonatal mesenchymal stem cell therapy shows promise for treating hair loss but needs more research.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Glypican-1 is important for blood vessel growth in hair follicles and could help treat hair loss.

Targeting the Wnt/β-catenin pathway may lead to better treatments for hair loss.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Microneedling mildly regrows hair in androgenetic alopecia but not in other types.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

The new device improves surgical accuracy by using a special dye and camera to see inside tissues.

AGA patients have higher heart disease risk.